BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 33543400)

  • 1. Combining targeted sequencing and ultra-low-pass whole-genome sequencing for accurate somatic copy number alteration detection.
    Fu J; Guo W; Yan C; Lv Z; Wang Y; Wang Z; Fan Z; Lei T
    Funct Integr Genomics; 2021 Mar; 21(2):161-169. PubMed ID: 33543400
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unbiased Detection of Somatic Copy Number Aberrations in cfDNA of Lung Cancer Cases and High-Risk Controls with Low Coverage Whole Genome Sequencing.
    Taylor F; Bradford J; Woll PJ; Teare D; Cox A
    Adv Exp Med Biol; 2016; 924():29-32. PubMed ID: 27753014
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low-pass Whole-genome Sequencing of Circulating Cell-free DNA Demonstrates Dynamic Changes in Genomic Copy Number in a Squamous Lung Cancer Clinical Cohort.
    Chen X; Chang CW; Spoerke JM; Yoh KE; Kapoor V; Baudo C; Aimi J; Yu M; Liang-Chu MMY; Suttmann R; Huw LY; Gendreau S; Cummings C; Lackner MR
    Clin Cancer Res; 2019 Apr; 25(7):2254-2263. PubMed ID: 30617129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SAAS-CNV: A Joint Segmentation Approach on Aggregated and Allele Specific Signals for the Identification of Somatic Copy Number Alterations with Next-Generation Sequencing Data.
    Zhang Z; Hao K
    PLoS Comput Biol; 2015 Nov; 11(11):e1004618. PubMed ID: 26583378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liquid biopsy detection of genomic alterations in pediatric brain tumors from cell-free DNA in peripheral blood, CSF, and urine.
    Pagès M; Rotem D; Gydush G; Reed S; Rhoades J; Ha G; Lo C; Fleharty M; Duran M; Jones R; Becker S; Haller M; Sinai CE; Goumnerova L; Golub TR; Love JC; Ligon KL; Wright KD; Adalsteinsson VA; Beroukhim R; Bandopadhayay P
    Neuro Oncol; 2022 Aug; 24(8):1352-1363. PubMed ID: 34984433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low-cost and clinically applicable copy number profiling using repeat DNA.
    Abujudeh S; Zeki SS; van Lanschot MCJ; Pusung M; Weaver JMJ; Li X; Noorani A; Metz AJ; Bornschein J; Bower L; Miremadi A; Fitzgerald RC; Morrissey ER; Lynch AG
    BMC Genomics; 2022 Aug; 23(1):599. PubMed ID: 35978291
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simultaneous Copy Number Alteration and Single-Nucleotide Variation Analysis in Matched Aqueous Humor and Tumor Samples in Children with Retinoblastoma.
    Schmidt MJ; Prabakar RK; Pike S; Yellapantula V; Peng CC; Kuhn P; Hicks J; Xu L; Berry JL
    Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37239954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Validation Framework for Somatic Copy Number Detection in Targeted Sequencing Panels.
    Chandramohan R; Reuther J; Gandhi I; Voicu H; Alvarez KR; Plon SE; Lopez-Terrada DH; Fisher KE; Parsons DW; Roy A
    J Mol Diagn; 2022 Jul; 24(7):760-774. PubMed ID: 35487348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of tools for identifying large copy number variations from ultra-low-coverage whole-genome sequencing data.
    Smolander J; Khan S; Singaravelu K; Kauko L; Lund RJ; Laiho A; Elo LL
    BMC Genomics; 2021 May; 22(1):357. PubMed ID: 34000988
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of Restriction Site-Associated DNA Sequencing (RAD-Seq) for Copy Number Variation and Triploidy Detection in Human.
    He JC; Li SY; He WZ; Xian JJ; Ma XY; Wang YC; Zhang MC; Ye GX; Liang B; Xia Q; Li Q
    Cytogenet Genome Res; 2021; 161(8-9):406-413. PubMed ID: 34657031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Using SAAS-CNV to Detect and Characterize Somatic Copy Number Alterations in Cancer Genomes from Next Generation Sequencing and SNP Array Data.
    Zhang Z; Hao K
    Methods Mol Biol; 2018; 1833():29-47. PubMed ID: 30039361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. hsegHMM: hidden Markov model-based allele-specific copy number alteration analysis accounting for hypersegmentation.
    Choo-Wosoba H; Albert PS; Zhu B
    BMC Bioinformatics; 2018 Nov; 19(1):424. PubMed ID: 30428830
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative analysis of methods for identifying somatic copy number alterations from deep sequencing data.
    Alkodsi A; Louhimo R; Hautaniemi S
    Brief Bioinform; 2015 Mar; 16(2):242-54. PubMed ID: 24599115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reliability of algorithmic somatic copy number alteration detection from targeted capture data.
    Rieber N; Bohnert R; Ziehm U; Jansen G
    Bioinformatics; 2017 Sep; 33(18):2791-2798. PubMed ID: 28472276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Appraising the relevance of DNA copy number loss and gain in prostate cancer using whole genome DNA sequence data.
    Camacho N; Van Loo P; Edwards S; Kay JD; Matthews L; Haase K; Clark J; Dennis N; Thomas S; Kremeyer B; Zamora J; Butler AP; Gundem G; Merson S; Luxton H; Hawkins S; Ghori M; Marsden L; Lambert A; Karaszi K; Pelvender G; Massie CE; Kote-Jarai Z; Raine K; Jones D; Howat WJ; Hazell S; Livni N; Fisher C; Ogden C; Kumar P; Thompson A; Nicol D; Mayer E; Dudderidge T; Yu Y; Zhang H; Shah NC; Gnanapragasam VJ; ; Isaacs W; Visakorpi T; Hamdy F; Berney D; Verrill C; Warren AY; Wedge DC; Lynch AG; Foster CS; Lu YJ; Bova GS; Whitaker HC; McDermott U; Neal DE; Eeles R; Cooper CS; Brewer DS
    PLoS Genet; 2017 Sep; 13(9):e1007001. PubMed ID: 28945760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genomic scoring to determine clinical benefit of immunotherapy by targeted sequencing.
    Kim HS; Cha H; Kim J; Park WY; Choi YL; Sun JM; Ahn JS; Ahn MJ; Park K; Lee SH
    Eur J Cancer; 2019 Oct; 120():65-74. PubMed ID: 31493723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genomic variations in plasma cell free DNA differentiate early stage lung cancers from normal controls.
    Xia S; Huang CC; Le M; Dittmar R; Du M; Yuan T; Guo Y; Wang Y; Wang X; Tsai S; Suster S; Mackinnon AC; Wang L
    Lung Cancer; 2015 Oct; 90(1):78-84. PubMed ID: 26233568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A computational approach to distinguish somatic vs. germline origin of genomic alterations from deep sequencing of cancer specimens without a matched normal.
    Sun JX; He Y; Sanford E; Montesion M; Frampton GM; Vignot S; Soria JC; Ross JS; Miller VA; Stephens PJ; Lipson D; Yelensky R
    PLoS Comput Biol; 2018 Feb; 14(2):e1005965. PubMed ID: 29415044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical-grade validation of whole genome sequencing reveals robust detection of low-frequency variants and copy number alterations in CLL.
    Klintman J; Barmpouti K; Knight SJL; Robbe P; Dreau H; Clifford R; Ridout K; Burns A; Timbs A; Bruce D; Antoniou P; Sosinsky A; Becq J; Bentley D; Hillmen P; Taylor JC; Caulfield M; Schuh AH
    Br J Haematol; 2018 Aug; 182(3):412-417. PubMed ID: 29808933
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical whole-genome sequencing from routine formalin-fixed, paraffin-embedded specimens: pilot study for the 100,000 Genomes Project.
    Robbe P; Popitsch N; Knight SJL; Antoniou P; Becq J; He M; Kanapin A; Samsonova A; Vavoulis DV; Ross MT; Kingsbury Z; Cabes M; Ramos SDC; Page S; Dreau H; Ridout K; Jones LJ; Tuff-Lacey A; Henderson S; Mason J; Buffa FM; Verrill C; Maldonado-Perez D; Roxanis I; Collantes E; Browning L; Dhar S; Damato S; Davies S; Caulfield M; Bentley DR; Taylor JC; Turnbull C; Schuh A;
    Genet Med; 2018 Oct; 20(10):1196-1205. PubMed ID: 29388947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.